Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Implantable Shock Absorber Can Prevent or Delay Knee Replacement in Osteoarthritis Patients

By HospiMedica International staff writers
Posted on 23 Sep 2022

Of the 14 million Americans suffering with the pain of knee osteoarthritis, more than half are under 65, making a knee replacement undesirable, as the prosthetic would likely need to be replaced in their lifetime. More...

Few options exist to get patients back on their feet or to slow joint degradation without major surgery that permanently alters the anatomy of the knee. Now, the results of a clinical trial show that an implantable device can not only make daily activities more comfortable, but delay the need for a knee replacement.

The new implantable device that works as a shock absorber was developed by researchers at The Ohio State University Wexner Medical Center (Columbus, OH, USA) and may soon give those with progressing knee osteoarthritis a new option to reduce pain, improve functionality and delay the need for a total knee replacement. As part of a clinical trial, the researchers implanted the new device designed to take strain off the knee of patients with osteoarthritis. Nearly three years later, the trial results are positive for nearly all of the participants. The device improved pain and functionality for more than 90% of the patients who received it. The results of the clinical trial with two years of patient follow-ups were recently presented, and the data has been submitted to the FDA.

“It is a shock absorber that is anchored to the bone, and when you’re walking or doing other activities it takes away about 30% of the stress on that knee every time you put weight on it,” said Dr. David Flanigan, professor of orthopedics and director of the Cartilage Restoration Program at The Ohio State University Wexner Medical Center. “Over 90% of the trial patients have been able to get back to the activities that have been causing them pain for quite some time and experienced significant improvements in pain and function.”

Related Links:
The Ohio State University


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ultrasound Needle Guidance System
SonoSite L25
Surgical Headlight
IsoTorch
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: A smartphone application displays a glucose concentration that was measured using the new sensor (Photo courtesy of Chuchu Chen and Yonghao Fu)

Wearable Device for Diabetics Could Replace Continuous Glucose Monitoring Systems

Monitoring blood glucose is essential for people with diabetes to prevent complications and maintain long-term health. Current continuous glucose monitoring systems require needles inserted under the skin,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.